In SMCs, a heightened colocalization of αSMA and Aβ immunofluorescence was noted in AD patients (control mean = 0.21, AD mean = 0.36, Z = −2.32, p = 0.0204) (Figure 1D). Here, ACTA1 is linked to Alzheimer disease.